ArticleCellular and molecular life sciences : CMLS2022

Targeting the E1 ubiquitin-activating enzyme (UBA1) improves elexacaftor/tezacaftor/ivacaftor efficacy towards F508del and rare misfolded CFTR mutants.

Christian Borgo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.